The Updated Model: An Adjusted Serum Alpha-Fetoprotein-Based Algorithm for Hepatocellular Carcinoma Detection With Hepatitis C Virus-Related Cirrhosis.
作者信息
White Donna L, Richardson Peter, Tayoub Nabiha, Davila Jessica A, Kanwal Fasiha, El-Serag Hashem B
机构信息
Section of Gastroenterology and Hepatology, Michael E. DeBakey VA Medical Center, Houston, Texas; Section of Health Services Research, Michael E. DeBakey VA Medical Center, Houston, Texas.
Section of Health Services Research, Michael E. DeBakey VA Medical Center, Houston, Texas.
出版信息
Gastroenterology. 2015 Dec;149(7):1986-7. doi: 10.1053/j.gastro.2015.10.004. Epub 2015 Oct 28.
Abstract
摘要
相似文献
1
The Updated Model: An Adjusted Serum Alpha-Fetoprotein-Based Algorithm for Hepatocellular Carcinoma Detection With Hepatitis C Virus-Related Cirrhosis.更新后的模型：一种基于血清甲胎蛋白调整的算法，用于丙型肝炎病毒相关性肝硬化患者肝细胞癌的检测
Gastroenterology. 2015 Dec;149(7):1986-7. doi: 10.1053/j.gastro.2015.10.004. Epub 2015 Oct 28.
2
A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis.一种新的基于实验室的算法，用于预测丙型肝炎和肝硬化患者发生肝细胞癌的风险。
Gastroenterology. 2014 May;146(5):1249-55.e1. doi: 10.1053/j.gastro.2014.01.045. Epub 2014 Jan 23.
3
Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model.丙型肝炎病毒感染合并肝细胞癌的早期检测：一种数学模型。
World J Gastroenterol. 2016 Apr 28;22(16):4168-82. doi: 10.3748/wjg.v22.i16.4168.
4
Characteristics of elderly hepatitis C virus-associated hepatocellular carcinoma patients.老年丙型肝炎病毒相关性肝细胞癌患者的特征。
J Gastroenterol Hepatol. 2013 Feb;28(2):357-64. doi: 10.1111/jgh.12057.
5
The use of AFP-based algorithm to predict hepatocellular carcinoma.
Gastroenterology. 2014 Sep;147(3):718. doi: 10.1053/j.gastro.2014.05.047. Epub 2014 Jul 27.
6
Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study.血清胰岛素样生长因子I评估作为预测丙型肝炎病毒相关性肝硬化患者发生肝细胞癌风险的有用工具：一项前瞻性研究。
Cancer. 2002 Dec 15;95(12):2539-45. doi: 10.1002/cncr.11002.
7
Alpha-fetoprotein and p53 autoantibodies in patients with chronic hepatitis C.慢性丙型肝炎患者的甲胎蛋白和p53自身抗体
Dig Dis Sci. 1995 Dec;40(12):2587-94. doi: 10.1007/BF02220446.
8
Natural history of chronic hepatitis B REVEALed.慢性乙型肝炎的自然史被揭示。
J Gastroenterol Hepatol. 2011 Apr;26(4):628-38. doi: 10.1111/j.1440-1746.2011.06695.x.
9
Computer-aided assessment of hepatic contour abnormalities as an imaging biomarker for the prediction of hepatocellular carcinoma development in patients with chronic hepatitis C.计算机辅助评估肝脏轮廓异常作为预测慢性丙型肝炎患者肝细胞癌发生的影像学生物标志物
Eur J Radiol. 2015 May;84(5):811-5. doi: 10.1016/j.ejrad.2015.01.009. Epub 2015 Jan 22.
10
Comparison of hepatocellular carcinoma with cirrhosis patients undergoing hepatic resection between hepatitis B and C infection.乙型和丙型肝炎感染的肝硬化患者行肝切除术后肝细胞癌的比较。
Hepatogastroenterology. 2013 Oct;60(127):1746-8.
引用本文的文献
1
Contemporary epidemiology of hepatocellular carcinoma: understanding risk factors and surveillance strategies.肝细胞癌的当代流行病学：了解风险因素和监测策略。
J Can Assoc Gastroenterol. 2024 Aug 9;7(5):331-345. doi: 10.1093/jcag/gwae025. eCollection 2024 Oct.
2
HES V2.0 outperforms GALAD for detection of HCC: A phase 3 biomarker study in the United States.在检测肝癌方面，HES V2.0优于GALAD：美国一项3期生物标志物研究。
Hepatology. 2025 Feb 1;81(2):465-475. doi: 10.1097/HEP.0000000000000953. Epub 2024 Jun 19.
3
Alpha-fetoprotein: Past, present, and future.甲胎蛋白：过去、现在与未来。
Hepatol Commun. 2024 Apr 12;8(5). doi: 10.1097/HC9.0000000000000422. eCollection 2024 May 1.
4
Risk stratification and early detection biomarkers for precision HCC screening.肝癌精准筛查的风险分层和早期检测生物标志物。
Hepatology. 2023 Jul 1;78(1):319-362. doi: 10.1002/hep.32779. Epub 2022 Oct 11.
5
Surveillance for hepatocellular carcinoma in chronic viral hepatitis: Is it time to personalize it?慢性病毒性肝炎肝细胞癌的监测：是否到了个体化的时代？
World J Gastroenterol. 2021 Sep 7;27(33):5536-5554. doi: 10.3748/wjg.v27.i33.5536.
6
Current and Emerging Tools for Hepatocellular Carcinoma Surveillance.当前和新兴的肝细胞癌监测工具。
Hepatol Commun. 2021 Dec;5(12):1972-1986. doi: 10.1002/hep4.1823. Epub 2021 Sep 17.
7
High Neutrophil-Lymphocyte Ratio and Delta Neutrophil-Lymphocyte Ratio Are Associated with Increased Mortality in Patients with Hepatocellular Cancer.高中性粒细胞与淋巴细胞比值和中性粒细胞与淋巴细胞比值差值与肝癌患者死亡率升高相关。
Dig Dis Sci. 2022 Jun;67(6):2666-2676. doi: 10.1007/s10620-021-07001-6. Epub 2021 May 3.
8
Assessment of a Deep Learning Model to Predict Hepatocellular Carcinoma in Patients With Hepatitis C Cirrhosis.评估深度学习模型在丙型肝炎肝硬化患者中预测肝细胞癌的价值。
JAMA Netw Open. 2020 Sep 1;3(9):e2015626. doi: 10.1001/jamanetworkopen.2020.15626.
9
Continued value of the serum alpha-fetoprotein test in surveilling at-risk populations for hepatocellular carcinoma.甲胎蛋白检测在监测肝细胞癌高危人群中的持续价值。
PLoS One. 2020 Aug 26;15(8):e0238078. doi: 10.1371/journal.pone.0238078. eCollection 2020.
10
Validation of the Updated Hepatocellular Carcinoma Early Detection Screening Algorithm in a Community-Based Cohort of Patients With Cirrhosis of Multiple Etiologies.验证多病因肝硬化患者基于社区队列的更新肝细胞癌早期检测筛查算法。
Clin Gastroenterol Hepatol. 2021 Jul;19(7):1443-1450.e6. doi: 10.1016/j.cgh.2020.07.065. Epub 2020 Aug 5.
本文引用的文献
1
A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis.一种新的基于实验室的算法，用于预测丙型肝炎和肝硬化患者发生肝细胞癌的风险。
Gastroenterology. 2014 May;146(5):1249-55.e1. doi: 10.1053/j.gastro.2014.01.045. Epub 2014 Jan 23.
2
Determinants of serum alpha-fetoprotein levels in hepatitis C-infected patients.丙型肝炎感染患者血清甲胎蛋白水平的决定因素。
Clin Gastroenterol Hepatol. 2012 Apr;10(4):428-33. doi: 10.1016/j.cgh.2011.11.025. Epub 2011 Dec 7.
3
Surveillance for hepatocellular carcinoma: development and validation of an algorithm to classify tests in administrative and laboratory data.肝细胞癌监测：在行政和实验室数据中分类检测的算法的制定和验证。
Dig Dis Sci. 2010 Nov;55(11):3241-51. doi: 10.1007/s10620-010-1387-y. Epub 2010 Sep 16.
4
Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis.丙型肝炎患者中检测肝细胞癌的甲胎蛋白检测特征。一项系统评价与批判性分析。
Ann Intern Med. 2003 Jul 1;139(1):46-50. doi: 10.7326/0003-4819-139-1-200307010-00012.
5
Phases of biomarker development for early detection of cancer.用于癌症早期检测的生物标志物开发阶段。
J Natl Cancer Inst. 2001 Jul 18;93(14):1054-61. doi: 10.1093/jnci/93.14.1054.
Zotero 插件